News
Immunai will generate a publicly accessible multi-omic dataset for a Parker Institute cohort of over 1,000 cancer patients.
Single-cell RNA sequencing (scRNA-seq) has confirmed that MM exhibits high intra-tumor heterogeneity, comprising a mixture of ...
What's been going on in the life sciences world this week? Check out Week in Brief for an overview of the biggest news.
Additionally, surviving cells from drug treatments will be subjected to scRNA-seq to reveal distinct cell cluster harboring resistance-related gene signatures. We also established ovarian cancer cell ...
Single-cell RNA sequencing, or scRNA-seq, lets you examine gene ... Scientists develop microcellular drones to deliver cancer-killing drugs ・Antibiotics, vaccinations and anti-inflammatory ...
Hosted on MSN23d
Drug screening platform identifies compound for reinvigorating exhausted CAR-T cellsManipulating the exhaustion process may improve the therapeutic efficacy of T cell responses in cancer. To address this ... tumor challenge and established a drug screening platform using these ...
TNBC kills 1 in 3 patients and while promising new drugs based on PARP ... in a murine model of TNBC. In scRNA-seq and spatial transcriptomics data, we defined striking relationships between less ...
This important revised manuscript presents compelling findings by delineating two molecularly distinct liver cancer subtypes through comprehensive ... In addition, we analyzed the scRNA-seq dataset ...
Proteins play a central role in virtually every disease. They are the building blocks of life, serving as essential ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results